{"id":"https://openalex.org/W2591448757","doi":"https://doi.org/10.2217/imt-2016-0147","title":"Risk of Endocrine Adverse Events in Cancer Patients Treated with PD-1 Inhibitors: A Systematic Review and Meta-Analysis","display_name":"Risk of Endocrine Adverse Events in Cancer Patients Treated with PD-1 Inhibitors: A Systematic Review and Meta-Analysis","alternate_titles":[],"publication_year":2017,"publication_date":"2017-02-24","ids":{"openalex":"https://openalex.org/W2591448757","doi":"https://doi.org/10.2217/imt-2016-0147","mag":"2591448757","pmid":"https://pubmed.ncbi.nlm.nih.gov/28231723"},"language":"en","primary_location":{"id":"doi:10.2217/imt-2016-0147","doi":"https://doi.org/10.2217/imt-2016-0147","is_oa":false,"landing_page_url":"https://doi.org/10.2217/imt-2016-0147","pdf_url":null,"source":{"id":"https://openalex.org/S71887004","display_name":"Immunotherapy","issn_l":"1750-743X","issn":["1750-743X","1750-7448"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immunotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2591448757"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Yan hong Shang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140680","display_name":"Affiliated Hospital of Hebei University","ror":"https://ror.org/049vsq398","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210140680"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yan hong Shang","raw_affiliation_strings":["Department of Medical Oncology, Affiliated Hospital of Hebei University, Baoding 071000, P R China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Affiliated Hospital of Hebei University, Baoding 071000, P R China","institution_ids":["https://openalex.org/I4210140680"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100433614","display_name":"Yu Zhang","orcid":"https://orcid.org/0000-0002-7384-0778","observed_orcids":["https://orcid.org/0000-0002-7384-0778"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yu Zhang","raw_affiliation_strings":["Department of internal Medicine, Baoding Children's Hospital, Baoding 071000, P R China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of internal Medicine, Baoding Children's Hospital, Baoding 071000, P R China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100678608","display_name":"Jinghua Li","orcid":"https://orcid.org/0000-0003-0533-9890","observed_orcids":["https://orcid.org/0000-0003-0533-9890"]},"institutions":[{"id":"https://openalex.org/I4210140680","display_name":"Affiliated Hospital of Hebei University","ror":"https://ror.org/049vsq398","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210140680"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jing hua Li","raw_affiliation_strings":["Department of Hepatobiliary Surgery, Affiliated Hospital of Hebei University, Baoding 071000, P R China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hepatobiliary Surgery, Affiliated Hospital of Hebei University, Baoding 071000, P R China","institution_ids":["https://openalex.org/I4210140680"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100432772","display_name":"Peng Li","orcid":"https://orcid.org/0000-0003-2030-1807","observed_orcids":["https://orcid.org/0000-0003-2030-1807","https://orcid.org/0009-0006-3632-5079"]},"institutions":[{"id":"https://openalex.org/I4210140680","display_name":"Affiliated Hospital of Hebei University","ror":"https://ror.org/049vsq398","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210140680"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peng Li","raw_affiliation_strings":["Departments of Ultrasound, Affiliated Hospital of Hebei University, Baoding 071000, P R China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Ultrasound, Affiliated Hospital of Hebei University, Baoding 071000, P R China","institution_ids":["https://openalex.org/I4210140680"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100430839","display_name":"Xi Zhang","orcid":"https://orcid.org/0000-0002-3869-3856","observed_orcids":["https://orcid.org/0000-0002-3869-3856"]},"institutions":[{"id":"https://openalex.org/I4210140680","display_name":"Affiliated Hospital of Hebei University","ror":"https://ror.org/049vsq398","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210140680"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Xi Zhang","raw_affiliation_strings":["Department of Radiation Oncology, Affiliated Hospital of Hebei University,\r212 East Yuhua Road,\rBaoding\r071000,\rHebei,\rP R China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiation Oncology, Affiliated Hospital of Hebei University,\r212 East Yuhua Road,\rBaoding\r071000,\rHebei,\rP R China","institution_ids":["https://openalex.org/I4210140680"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6961,"has_fulltext":false,"cited_by_count":41,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.60846352,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"9","issue":"3","first_page":"261","last_page":"272"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10293","display_name":"Thyroid Disorders and Treatments","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10832","display_name":"Pituitary Gland Disorders and Treatments","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pd-1-inhibitors","display_name":"PD-1 inhibitors","score":0.9980000257492065},{"id":"https://openalex.org/keywords/endocrine-adverse-events","display_name":"endocrine adverse events","score":0.9150000214576721},{"id":"https://openalex.org/keywords/hypothyroidism","display_name":"hypothyroidism","score":0.9829999804496765},{"id":"https://openalex.org/keywords/hyperthyroidism","display_name":"hyperthyroidism","score":1.0},{"id":"https://openalex.org/keywords/hypophysitis","display_name":"hypophysitis","score":0.9940000176429749},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.8299999833106995},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.8510000109672546},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.6119999885559082},{"id":"https://openalex.org/keywords/thyroid-disease","display_name":"thyroid dysfunction","score":0.3050000071525574}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.902265191078186},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.8630605936050415},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6951313018798828},{"id":"https://openalex.org/C2779699572","wikidata":"https://www.wikidata.org/wiki/Q421052","display_name":"Everolimus","level":2,"score":0.6080771088600159},{"id":"https://openalex.org/C2780194577","wikidata":"https://www.wikidata.org/wiki/Q4120169","display_name":"Hypophysitis","level":4,"score":0.5605136752128601},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.544292151927948},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5391535758972168},{"id":"https://openalex.org/C82789193","wikidata":"https://www.wikidata.org/wiki/Q2142611","display_name":"Relative risk","level":3,"score":0.5060121417045593},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4868575930595398},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.4380418062210083},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.35810595750808716},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.15562206506729126},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.15156841278076172},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.12234058976173401},{"id":"https://openalex.org/C2777658017","wikidata":"https://www.wikidata.org/wiki/Q156871","display_name":"Pituitary gland","level":3,"score":0.11025714874267578},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068338","descriptor_name":"Everolimus","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000068818","descriptor_name":"Cetuximab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000074324","descriptor_name":"Ipilimumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006980","descriptor_name":"Hyperthyroidism","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D007037","descriptor_name":"Hypothyroidism","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D012306","descriptor_name":"Risk","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061026","descriptor_name":"Programmed Cell Death 1 Receptor","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.2217/imt-2016-0147","doi":"https://doi.org/10.2217/imt-2016-0147","is_oa":false,"landing_page_url":"https://doi.org/10.2217/imt-2016-0147","pdf_url":null,"source":{"id":"https://openalex.org/S71887004","display_name":"Immunotherapy","issn_l":"1750-743X","issn":["1750-743X","1750-7448"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immunotherapy","raw_type":"journal-article"},{"id":"pmid:28231723","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28231723","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immunotherapy","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"},{"display_name":"Meta-Analysis","id":"https://openalex.org/study-designs/meta-analysis"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":42,"referenced_works":["https://openalex.org/W204046373","https://openalex.org/W1605630196","https://openalex.org/W1809627231","https://openalex.org/W1893566975","https://openalex.org/W1972755885","https://openalex.org/W1982228885","https://openalex.org/W1982488143","https://openalex.org/W1985110807","https://openalex.org/W1986215651","https://openalex.org/W1987030266","https://openalex.org/W2007872832","https://openalex.org/W2017712207","https://openalex.org/W2022073464","https://openalex.org/W2036195858","https://openalex.org/W2050407789","https://openalex.org/W2085247907","https://openalex.org/W2096322385","https://openalex.org/W2104347254","https://openalex.org/W2104549050","https://openalex.org/W2107328434","https://openalex.org/W2112121482","https://openalex.org/W2125435699","https://openalex.org/W2127446775","https://openalex.org/W2127505226","https://openalex.org/W2128035403","https://openalex.org/W2128758225","https://openalex.org/W2131754429","https://openalex.org/W2152897456","https://openalex.org/W2156353875","https://openalex.org/W2166107256","https://openalex.org/W2166662937","https://openalex.org/W2177405394","https://openalex.org/W2198093519","https://openalex.org/W2222086386","https://openalex.org/W2230051264","https://openalex.org/W2233818050","https://openalex.org/W2278440281","https://openalex.org/W2293531514","https://openalex.org/W2305396859","https://openalex.org/W2527905628","https://openalex.org/W2529484692","https://openalex.org/W2529904548"],"related_works":["https://openalex.org/W4396596929","https://openalex.org/W3179376270","https://openalex.org/W2799536814","https://openalex.org/W2996119738","https://openalex.org/W2278440281","https://openalex.org/W3115633387","https://openalex.org/W2790288762","https://openalex.org/W2921353943","https://openalex.org/W4391030121","https://openalex.org/W4388648357"],"abstract_inverted_index":{"AIM:":[0],"We":[1],"conducted":[2],"this":[3],"meta-analysis":[4],"to":[5,96],"investigate":[6],"the":[7,48,83,102],"overall":[8],"incidence":[9],"and":[10,25,63,89,124],"risk":[11,49,84,103,120],"of":[12,50,85,104,121],"endocrine":[13],"complications":[14],"in":[15],"cancer":[16],"patients":[17],"treated":[18],"with":[19,37,80,91,112,117],"PD-1":[20,44,92,113],"inhibitors.":[21],"METHODS:":[22],"Pubmed,":[23],"Embase":[24],"oncology":[26],"conference":[27],"proceedings":[28],"were":[29],"searched":[30],"for":[31,76,128],"relevant":[32],"studies.":[33],"RESULTS:":[34],"In":[35],"comparison":[36],"chemotherapy":[38],"or":[39,41],"everolimus":[40],"cetuximab":[42],"control,":[43,82],"inhibitors":[45,93,114],"significantly":[46],"increased":[47,119],"all":[51,86],"grade":[52,87],"hypothyroidism":[53,90,123],"(relative":[54,65],"risk:":[55,66],"6.38;":[56],"95%":[57,68],"CI:":[58,69],"3.78-10.77;":[59],"p":[60,71],"<":[61,72],"0.001)":[62],"hyperthyroidism":[64,88],"5.08;":[67],"2.55-10.14;":[70],"0.001),":[73],"but":[74,126],"not":[75,127],"hypophysitis.":[77,129],"When":[78],"compared":[79],"ipilimumab":[81],"monotherapy":[94],"seemed":[95],"be":[97],"higher":[98],"than":[99,108],"ipilimumab,":[100],"while":[101],"hypophysitis":[105],"was":[106],"lower":[107],"ipilimumab.":[109],"CONCLUSION:":[110],"Treatment":[111],"is":[115],"associated":[116],"an":[118],"developing":[122],"hyperthyroidism,":[125]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2591448757","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":5}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2017-03-03T00:00:00"}
